tiprankstipranks
Kiora Pharmaceuticals (KPRX)
NASDAQ:KPRX
US Market

Kiora Pharmaceuticals (KPRX) Financial Statements

483 Followers

Kiora Pharmaceuticals Financial Overview

Kiora Pharmaceuticals's market cap is currently $9.76M. The company's EPS TTM is $-1.59; its P/E ratio is -0.31; Kiora Pharmaceuticals is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is $-0.71. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 16.00M$ 0.00$ 0.00$ 0.00
Gross Profit$ -24.80K$ 16.00M$ 0.00$ 0.00$ 0.00
Operating Income$ -9.46M$ 4.51M$ -12.59M$ -12.31M$ -14.24M
EBITDA$ -9.43M$ 5.70M$ -12.36M$ -13.65M$ -13.91M
Net Income$ -10.84M$ 3.59M$ -12.51M$ -13.58M$ -13.77M
Balance Sheet
Cash & Short-Term Investments$ 17.09M$ 26.79M$ 2.45M$ 5.96M$ 7.85M
Total Assets$ 24.25M$ 36.48M$ 13.71M$ 18.68M$ 20.13M
Total Debt$ 368.26K$ 57.17K$ 106.89K$ 105.78K$ 209.41K
Net Debt$ -8.33M$ -3.74M$ -2.35M$ -5.86M$ -7.65M
Total Liabilities$ 8.13M$ 10.72M$ 7.60M$ 7.27M$ 5.55M
Stockholders' Equity$ 16.13M$ 25.76M$ 6.11M$ 11.41M$ 14.58M
Cash Flow
Free Cash Flow$ -10.07M$ 8.55M$ -9.56M$ -10.43M$ -10.74M
Operating Cash Flow$ -9.96M$ 8.56M$ -9.56M$ -10.43M$ -10.68M
Investing Cash Flow$ 14.43M$ -22.66M$ 0.00$ 6.38K$ -157.02K
Financing Cash Flow$ 265.65K$ 15.50M$ 5.97M$ 8.62M$ 17.58M
Currency in USD

Kiora Pharmaceuticals Earnings and Revenue History

Kiora Pharmaceuticals Debt to Assets

Kiora Pharmaceuticals Cash Flow

Kiora Pharmaceuticals Forecast EPS vs Actual EPS